comparemela.com

Latest Breaking News On - Indaptus therapeutic - Page 1 : comparemela.com

Indaptus Therapeutics Expands Digital Presence with Launch of Social Media Channels

NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pion.

Equities Analysts Offer Predictions for Indaptus Therapeutics, Inc s FY2023 Earnings (NASDAQ:INDP)

Indaptus Therapeutics, Inc. (NASDAQ:INDP – Free Report) – Analysts at HC Wainwright increased their FY2023 earnings estimates for shares of Indaptus Therapeutics in a research report issued on Tuesday, November 7th. HC Wainwright analyst R. Selvaraju now expects that the company will earn ($1.90) per share for the year, up from their previous estimate of […]

Here s Why We re Watching Indaptus Therapeutics (NASDAQ:INDP) Cash Burn Situation

Just because a business does not make any money, does not mean that the stock will go down. For example, although.

HC Wainwright Comments on Indaptus Therapeutics, Inc s Q3 2023 Earnings (NASDAQ:INDP)

HC Wainwright Comments on Indaptus Therapeutics, Inc s Q3 2023 Earnings (NASDAQ:INDP)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Q2 2023 EPS Estimates for Indaptus Therapeutics, Inc (NASDAQ:INDP) Increased by Analyst

Indaptus Therapeutics, Inc. (NASDAQ:INDP – Get Rating) – Research analysts at HC Wainwright upped their Q2 2023 earnings per share (EPS) estimates for Indaptus Therapeutics in a research report issued on Monday, March 20th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per share of ($0.63) for the quarter, up […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.